NGS-Based RNA-Sequencing Market

Table of Content

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions

2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis

2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources

2.4.2. Primary Research
2.4.2.1. Introduction

2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative

2.4.2.3. Advantages

2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions

2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Hospitals

2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity

2.4.3. Analytical Tools and Databases

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach

3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)

3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis

3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation

3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of NGS-Based RNA-Sequencing Market
6.2.1. Key Characteristics of NGS-Based RNA-Sequencing
6.2.2. Key Applications of the NGS-Based RNA-Sequencing
6.2.3. Challenges Associated with NGS-Based RNA-Sequencing

6.3. Future Perspective

7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. NGS-Based RNA-Sequencing Product and Service Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters

7.2.4. NGS-Based RNA-Sequencing Market: Overall Market Landscape
7.2.4.1. Analysis by Offering Type
7.2.4.2. Analysis by Workflow Type
7.2.4.3. Analysis by Technology Type
7.2.4.4. Analysis by Application Area
7.2.4.5. Analysis by End User

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodologies

8.4. Company Competitiveness Analysis: NGS-Based RNA-Sequencing Product and Service Providers
8.4.1. NGS-Based RNA-Sequencing Product and Service Providers Based in North America (Peer Group 1)
8.4.2. NGS-Based RNA-Sequencing Product and Service Providers Based in Europe (Peer Group 2)
8.4.3. NGS-Based RNA-Sequencing Product and Service Providers Based in Asia-Pacific (Peer Group 3)
8.4.4. NGS-Based RNA-Sequencing Product and Service Providers Based in Middle East and North Africa, and Latin America (Peer Group 4)

8.5. Key Findings

9. COMPANY PROFILES
9.1. Chapter Overview
9.2. 10x Genomics
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service / Product Portfolio
9.2.4. Recent Developments and Future Outlook

* Similar details are presented for other below mentioned companies based on information in the public domain

9.3. Agilent Technologies
9.4. BGI Genomics
9.5. Bio- Rad Laboratories
9.6. Eurofins Genomics
9.7. Genewiz
9.8. GATC Biotech
9.9. Macrogen
9.10. Novogene
9.11. Illumina
9.12. Lexogen
9.13. Oxford Nanopore Technologies
9.14. Pacific Biosciences
9.15. Perkin Elmer
9.16. Qiagen
9.17. Roche
9.18. Singular Genomics
9.19. Thermo Fisher Scientific
9.20. Takara Bio
9.21. Zymo Research

10. SWOT ANALYSIS

11. MARKET IMPACT ANALYSIS
11.1. Chapter Overview
11.2. Market Drivers
11.3. Market Restraints
11.4. Market Opportunities
11.5. Market Challenges
11.6. Conclusion

12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Trends Disruption Impacting Market
12.4. Global NGS-Based RNA-Sequencing Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

12.5. Multivariate Scenario Analysis
12.5.1. Conservative Scenario
12.5.2. Optimistic Scenario

12.6. Key Market Segmentations

13. MARKET OPPORTUNITIES BASED ON TYPE OF OFFERING
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Revenue Shift Analysis
13.4. Market Movement Analysis
13.5. Penetration-Growth (P-G) Matrix

13.6. NGS-Based RNA-Sequencing Market for Consumables: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.1. NGS-Based RNA-Sequencing Market for Extraction & Purification Kits: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.2. NGS-Based RNA-Sequencing Market for Library Preparation Kits: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.3. NGS-Based RNA-Sequencing Market for Sequencing Reagents & Flow Cells: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.6.4. NGS-Based RNA-Sequencing Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

13.7. NGS-Based RNA-Sequencing Market for Instruments: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

13.8. NGS-Based RNA-Sequencing Market for Services: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.8.1. NGS-Based RNA-Sequencing Market for RNA-Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.8.2. NGS-Based RNA-Sequencing Market for Bioinformatics & Data Analysis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

13.9. Data Triangulation and Validation

14. MARKET OPPORTUNITIES BASED ON TYPE OF WORKFLOW
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Revenue Shift Analysis
14.4. Market Movement Analysis
14.5. Penetration-Growth (P-G) Matrix
14.6. NGS-Based RNA-Sequencing Market for Pre-Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.7. NGS-Based RNA-Sequencing Market for Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.8. NGS-Based RNA-Sequencing Market for Data Analysis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.9. Data Triangulation and Validation

15. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Revenue Shift Analysis
15.4. Market Movement Analysis
15.5. Penetration-Growth (P-G) Matrix
15.6. NGS-Based RNA-Sequencing Market for Nanopore Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7. NGS-Based RNA-Sequencing Market for Sequencing by Synthesis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.8. NGS-Based RNA-Sequencing Market for Ion Semiconductor Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.9. NGS-Based RNA-Sequencing Market for Single-Molecule Real-Time Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.10. Data Triangulation and Validation

16. MARKET OPPORTUNITIES BASED ON APPLICATION AREA
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix

16.6. NGS-Based RNA-Sequencing Market for Drug Discovery & Development: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.6.1. NGS-Based RNA-Sequencing Market for Oncology: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.6.2. NGS-Based RNA-Sequencing Market for Infectious Diseases: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.6.3. NGS-Based RNA-Sequencing Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

16.7. NGS-Based RNA-Sequencing Market for Clinical Diagnostics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.8. NGS-Based RNA-Sequencing Market for Other Applications: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.9. Data Triangulation and Validation

17. MARKET OPPORTUNITIES BASED ON END USER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. NGS-Based RNA-Sequencing Market for Academic & Research Institutes: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. NGS-Based RNA-Sequencing Market for Pharmaceutical & Biotechnology Companies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.8. NGS-Based RNA-Sequencing Market for Hospitals & Clinics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.9. NGS-Based RNA-Sequencing Market for Other End Users: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.10. Data Triangulation and Validation

18. MARKET OPPORTUNITIES FOR NGS-BASED RNA-SEQUENCING IN NORTH AMERICA
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix

18.6. NGS-Based RNA-Sequencing Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.1. NGS-Based RNA-Sequencing Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.2. NGS-Based RNA-Sequencing Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.6.3. NGS-Based RNA-Sequencing Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

18.7. Data Triangulation and Validation

19. MARKET OPPORTUNITIES FOR NGS-BASED RNA-SEQUENCING IN EUROPE
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix

19.6. NGS-Based RNA-Sequencing Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.1. NGS-Based RNA-Sequencing Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.2. NGS-Based RNA-Sequencing Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.3. NGS-Based RNA-Sequencing Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.4. NGS-Based RNA-Sequencing Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.5. NGS-Based RNA-Sequencing Market in the UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.6. NGS-Based RNA-Sequencing Market in Rest of Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

19.7. Data Triangulation and Validation

20. MARKET OPPORTUNITIES FOR NGS-BASED RNA-SEQUENCING IN ASIA-PACIFIC
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix

20.6. NGS-Based RNA-Sequencing Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.1. NGS-Based RNA-Sequencing Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.2. NGS-Based RNA-Sequencing Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.3. NGS-Based RNA-Sequencing Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.4. NGS-Based RNA-Sequencing Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.5. NGS-Based RNA-Sequencing Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.7. Data Triangulation and Validation

21. MARKET OPPORTUNITIES FOR NGS-BASED RNA-SEQUENCING IN MIDDLE EAST AND NORTH AFRICA (MENA)
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix

21.6. NGS-Based RNA-Sequencing Market in Middle East and North Africa (MENA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.1. NGS-Based RNA-Sequencing Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 205)
21.6.2. NGS-Based RNA-Sequencing Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.3. NGS-Based RNA-Sequencing Market in United Arab Emirates (UAE): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR NGS-BASED RNA-SEQUENCING IN LATIN AMERICA
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix

22.6. NGS-Based RNA-Sequencing Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.1. NGS-Based RNA-Sequencing Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.2. NGS-Based RNA-Sequencing Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

22.7. Data Triangulation and Validation

23. APPENDIX 1: TABULATED DATA

24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

25. CUSTOMIZATION OPPORTUNITIES

26. ROOTS SUBSCRIPTION SERVICES

27. AUTHOR DETAIL